Goldman Sachs’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
Other funds holding ELAN
VPM
VCM
Goldman Sachs's ELAN Position: Q1 2026 in Review
Goldman Sachs reduced its Elanco Animal Health (ELAN) stake by 3.6% in Q1 2026, selling an estimated $1.31M and leaving 1,434,135 shares worth $34.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1909.
Goldman Sachs first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $345M in Q2 2021. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.
- Goldman Sachs held 1,434,135 shares of Elanco Animal Health worth $34.3M as of Q1 2026.
- Goldman Sachs sold 53,574 Elanco Animal Health shares in Q1 2026, an estimated $1.31M.
- Elanco Animal Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #1909 holding.
- Goldman Sachs first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
- Goldman Sachs's Elanco Animal Health position peaked at $345M in Q2 2021.
- 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.